EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1

CUSIP: 29089QAB1

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Debt / NOTE 2.875% 1/1
Market price (% of par)
144.12%
Total 13F principal
$214,385,363
Principal change
-$4,790,496
Total reported market value
$308,628,161
Number of holders
27
Value change
+$44,874
Number of buys
16
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 29089QAB1?
CUSIP 29089QAB1 identifies 29089QAB1 - EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 as of Q3 2017

As of 30 Sep 2017, EMERGENT BIOSOLUTIONS INC - NOTE 2.875% 1/1 was held by 27 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $214,385,363 in principal (par value) of the bond. The largest 10 bondholders included Calamos Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, CNH PARTNERS LLC, D. E. Shaw & Co., Inc., UBS ASSET MANAGEMENT AMERICAS INC, Weiss Asset Management LP, LAZARD ASSET MANAGEMENT LLC, Opera Trading Capital, CSS LLC/IL, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 27 institutional bondholders reporting positions for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.